Frontlight ResearchEarly access
Sarcoma trials in United States
241 of 301 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- Where
- Ann Arbor, Aurora, Baltimore, Bethesda, Boston, Charlottesville, Chicago, Houston, Los Angeles, Miami, New Lenox, Orland Park, Pittsburgh, St Louis
- Age
- 18 years and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05711615 - Phase 2Taking peopleIscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
- Where
- Hackensack, Houston
- Age
- 8 years to 30 years
- People
- 32
- Run by
- Hackensack Meridian Health
See details and how to joinNCT05726383 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseTaking peopleDistance-Based Exercise to Preserve Function and Prevent Disability
- Where
- Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, Winston-Salem
- Age
- 18 years and over
- People
- 104
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07059884 - Phase 2Taking peopleThe CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma
- Where
- Chapel Hill, Charleston, Charlotte, Columbia, Durham, Greenville, Winston-Salem
- Age
- 7 years to 22 years
- People
- 46
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07560826 - Phase 1Taking peoplePhase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- Where
- Bethesda
- Age
- 3 years to 35 years
- People
- 54
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02390752 - Phase 1Taking peopleT Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
- Where
- Houston
- Age
- 12 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06474676 - Phase 2Taking peopleEvaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
- Where
- Memphis
- Age
- Up to 21 years
- People
- 41
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07428993 - Phase 2Taking peoplePhase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07283731 - Early phase 1Taking peoplePilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
- Where
- Phildelphia
- Age
- 12 years to 17 years
- People
- 20
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07658768 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 1Taking peopleEvaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Where
- Ann Arbor, Baltimore, Boston, Houston, Los Angeles, New York, Philadelphia, Pittsburgh, Rochester
- Age
- 2 years and over
- People
- 50 worldwide
- Run by
- Amgen
See details and how to joinNCT07297979 - No phaseNot yet taking people in United Statesmy.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Where
- Boston
- Age
- 15 years to 24 years
- People
- 143
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07516353 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Age
- 18 years to 90 years
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - Phase 1Taking peopleAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Where
- Madison
- Age
- 7 months to 21 years
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT02508038 - Phase 1Taking peoplePhase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Where
- Cincinnati, Houston, Palo Alto, Philadelphia, San Francisco
- Age
- 24 months to 18 years
- People
- 20 worldwide
- Run by
- ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00 - Phase 2Taking peopleCobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Where
- Baltimore, Boston, Dallas, Houston, Little Rock, Madison, Memphis, New York, Orange, Phoenix, San Francisco, Washington D.C.
- People
- 90
- Run by
- Carl Allen
See details and how to joinNCT04079179 - Phase 2Taking peopleA Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Where
- Chicago, Los Angeles, New York
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- Sarcoma Alliance for Research through Collaboration
See details and how to joinNCT06942442 - Phase 2Taking peopleA Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Where
- Atlanta, Basking Ridge, Boston, Chicago, Cincinnati, Commack, Fort Worth, Harrison, Los Angeles, Middletown, Montvale, New York, Palo Alto, Rockville Centre, St Louis, Washington D.C.
- Age
- 12 months and over
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05985161 - Phase 1/2Taking peopleSTC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Where
- Boston, Cleveland, Fairfax, Grand Rapids, Houston, Irving, Lake Success, Miami, New York, San Antonio, San Francisco, Seattle
- Age
- 18 years and over
- People
- 107
- Run by
- STORM Therapeutics LTD
See details and how to joinNCT06975293 - Phase 2Taking peopleA Study of Ivonescimab in People With Leiomyosarcoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07516925 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - Phase 1/2Taking peopleTesting the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
- Where
- Houston
- Age
- 18 years and over
- People
- 74
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06498648